Nanobiotix and MD Anderson Cancer Center announced a large-scale, comprehensive clinical research collaboration to evaluate innovative strategies for treating patients with head and neck, pancreatic, thoracic, lung, gastrointestinal, and genitourinary cancers.
Adaptive Biotechnologies and Genentech said they have entered into a worldwide collaboration and license agreement to develop, manufacture and commercialize novel neoantigen directed T-cell therapies for the treatment of a broad range of cancers.
Maureen Testoni has been named as the 340B Health CEO by the e 340B Health board of directors.
The American Society of Clinical Oncology has elected Lori Pierce, a long-time member and volunteer, to serve as its president for the term beginning in June 2020. She will take office as president-elect during the ASCO annual meeting in Chicago in June 2019.xxx:moreAn ASCO member since 1992, Pierce is a radiation oncologist, professor, and vice provost f
The Community Oncology Alliance announced long-time board member and volunteer Michael Diaz, a practicing medical oncologist at Florida Cancer Specialists & Research Institute, has been elected president of COA. He took office for a one-year term on Jan. 1.
José Baselga was asked to resign as one of the editors-in-chief of Cancer Discovery, a journal published by the American Association for Cancer Research.
Bristol-Myers Squibb Co. and Celgene Corp. have entered into a definitive merger agreement under which BMS will acquire Celgene in a cash and stock transaction with an equity value of approximately $74 billion.
Moffitt Cancer Center has recruited five research scientists:
Anil K. Rustgi, an expert in gastrointestinal tumors, was named director of the Herbert Irving Comprehensive Cancer Center at Columbia University Irving Medical Center and NewYork-Presbyterian/Columbia University Irving Medical Center.
Addressing health disparities in the Dallas/Fort Worth area will be a key focus for Jasmin Tiro in her new position as associate director of community, outreach, engagement, and equity in the UT Southwestern Simmons Cancer Center.
